Analysts Offer Predictions for CRSP FY2024 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Brookline Capital Management lowered their FY2024 earnings estimates for CRISPR Therapeutics in a note issued to investors on Tuesday, November 5th. Brookline Capital Management analyst L. Cann now forecasts that the company will post earnings per share of ($5.18) for the year, down from their prior estimate [...]
ONLY AVAILABLE IN PAID PLANS
Published by: americanbankingnews
Read full article here: https://www.americanbankingnews.com/2024/11/10/analysts-offer-predictions-for-crsp-fy2024-earnings.html
- Market News
- Analyst Articles - Estimates
- Abmn Staff
- Business
- United States Of America
